In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

European Commission predicts issuing recast proposals in early 2012; key EU committee created

This article was originally published in RAJ Devices

Executive Summary

European Commission proposals for the recast of the EU directives on medical devices, active implantable medical devices and in vitro diagnostics could be finalised by the beginning of 20121. In the meantime, another endeavour to have emerged from the recast deliberations has taken a step forward, after member states set up a Central Management Committee (CMC) that they envisage will support the resources-challenged commission in ensuring consistency in the implementation of the legal requirements throughout the EU.

Latest Headlines
See All
UsernamePublicRestriction

Register

SC096327

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel